Prevalence of gastric mucosal interleukin-1 polymorphisms in Kenyan patients with advanced gastric cancer

South African Medical Journal

Volumn 99, Issue 2, 2009, Pages 95-97

  Nyerere, Kimang'a ^a,b   Sayed, Shahin ^a   Revathi, Gunturu ^a   Ojwang, Peter ^a   Matiru, Viviene ^b   Devani, Smita ^a   Shah, Mahesh ^a   Kariuki, Samuel ^c  

^a AGA KHAN UNIVERSITY   (Kenya)

^b KENYATTA UNIVERSITY   (Kenya)

^c KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA; IL1RN PROTEIN, HUMAN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ADULT; ADVANCED CANCER; AGED; CANCER EPIDEMIOLOGY; CHROMOSOME 2Q; FEMALE; GENE CLUSTER; GENETIC POLYMORPHISM; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; INTESTINE METAPLASIA; KENYA; LETTER; MALE; STOMACH BIOPSY; STOMACH CANCER; STOMACH MUCOSA; COHORT ANALYSIS; GENE FREQUENCY; GENETICS; MICROBIOLOGY; MIDDLE AGED; PREVALENCE; SIGNET RING CARCINOMA; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH TUMOR;

ADULT; AGED; CARCINOMA, SIGNET RING CELL; COHORT STUDIES; FEMALE; GASTRIC MUCOSA; GENE FREQUENCY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1BETA; KENYA; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; STOMACH NEOPLASMS;

EID: 66149109664     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (9)

1. John C. Atherton. The pathogenesis of Helicobacter pylori-induced gastro-duodenal diseases. Annu Rev Pathol Mech Dis 2006; 1: 63-96.
2. IARC Working Group on the Evaluation of Carcinogenic Risk to Humans, 7-14 June, Lyon. IARC Monogr Eval Carcinog Risks Hum 1994; 61: 1-241.
3. Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001; 345: 784-789.
4. El-Omar EM, Rabkin CS, Gammon MD, et al. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology 2003; 124: 1193-1201.
5. Miyabayashi H, Furihata K, Shimizu T, Ueno I, Akamatsu T. Influence of oral Helicobacter pylori on the success of erradication therapy against gastric Helicobacter pylori. Helicobacter 2000; 5: 30-37.
6. Hwang IR, Kodama T, Kikuchi S, et al. Effect of interleukin-1 polymorphisms on gastric mucosal interleukin 1beta production in Helicobacter pylori infection. Gastroenterology 2002; 123: 1793-1803.
7. Vilaichone RK, Mahachai V, Tumwasorn S, Wu J-Y, Graham DY, Yamaoka Y. Molecular epidemiology and outcome of Helicobacter pylori infection in Thailand: a Cultural Cross Roads. Scand J Gastroenterol 2005; 40: 520-539.
8. Ogutu E, Kang'ethe S, Nyaboja L. Endoscopic findings and prevalence of H. pylori in Kenyan patients with dyspepsia. East Afr Med J 1998; 75: 85-89.
9. Kikuchi S, Wada O, Nakajima T, et al. Serum anti-Helicobacter pylori antibody and gastric carcinoma among young adults. Cancer 1995; 75: 2789-2793.